Core Laboratories
CLB
384 hedge funds and large institutions have $5.61B invested in Core Laboratories in 2016 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 130 increasing their positions, 130 reducing their positions, and 38 closing their positions.
55% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 38
52% more call options, than puts
Call options by funds: $40.4M | Put options by funds: $26.6M
11% more capital invested
Capital invested by funds: $5.04B → $5.61B (+$577M)
5% more funds holding
Funds holding: 367 → 384 (+17)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
0% more repeat investments, than reductions
Existing positions increased: 130 | Existing positions reduced: 130
2.94% less ownership
Funds ownership: 104.61% → 101.68% (-2.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$46.3M |
| 2 |
Renaissance Technologies
New York
|
+$29.1M |
| 3 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$26.2M |
| 4 |
WCM Investment Management
Laguna Beach,
California
|
+$22M |
| 5 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
+$20.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EARNEST Partners
Atlanta,
Georgia
|
-$41.4M |
| 2 |
WP
Wedgewood Partners
St Louis,
Missouri
|
-$32.1M |
| 3 |
Morgan Stanley
New York
|
-$26.3M |
| 4 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$16M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$15M |
CLB Hedge Fund Activity: Q2 2016 in Review
384 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q2 2016, worth a combined $5.61B — up 11% from $5.04B a quarter earlier.
Buyers outnumbered sellers: 59 funds opened new CLB positions and 38 closed out — a net gain of 21 holders — while 130 added to existing stakes and 130 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $46.3M. The largest seller was EARNEST Partners, cutting an estimated $41.4M.
- 384 institutional investors held Core Laboratories (CLB) as of Q2 2016, up from 367 in Q1 2016.
- Funds reported $5.61B of Core Laboratories stock for Q2 2016, up 11% quarter-over-quarter.
- 59 funds opened new Core Laboratories positions in Q2 2016 and 38 closed out, a net change of +21 holders.
- The largest Core Laboratories buyer in Q2 2016 was Royal Bank of Canada, an estimated $46.3M added.
- The largest Core Laboratories seller in Q2 2016 was EARNEST Partners, an estimated $41.4M sold.
Based on aggregated 13F filings for Q2 2016.